"Sujata Birla Hospital"

During the past decade, Sujata Birla Hospital & Research Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sujata Birla Hospital & Research Centre" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sujata Birla Hospital & Research Centre" are "Bipolar Depression" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "Sujata Birla Hospital & Research Centre" in a lesser frequency.

Most popular intervention types in "Sujata Birla Hospital & Research Centre" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "Placebo + (lithium or divalproex)" (1 trials), "lurasidone" (1 trials) and "lurasidone + (lithium or divalproex)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sujata Birla Hospital & Research Centre" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Sujata Birla Hospital & Research Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Sujata Birla Hospital & Research Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sujata Birla Hospital & Research Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".